Lavipharm

Lavipharm EBIT per Share

The EBIT per Share of Lavipharm (LAVI.AT) as of Oct 11, 2026 is 0.05 EUR. In the previous year, EBIT per Share was 0.03 EUR — a change of 64.54% (higher).

EBIT per Share

0.05EUR

YoY

64.54%

Last updated:

EBIT per Share of Lavipharm is 2025 0.05 EUR. EBIT per Share of Lavipharm was 2024 0.03 EUR. It decreases by 64.54% higher compared to the previous year.

The Lavipharm EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
0.03 EUR
Jan 1, 2024
0.03 EUR
Jan 1, 2025
0.05 EUR
Jan 1, 2026 (e)
0.07 EUR
Jan 1, 2027 (e)
0.19 EUR
Jan 1, 2028 (e)
0.26 EUR
Jan 1, 2029 (e)
0.28 EUR
Jan 1, 2030 (e)
0.29 EUR
The Lavipharm EBIT per Share history
YEAREBIT per ShareYoY
est0.29EUR+5.31%
est0.28EUR+5.61%
est0.26EUR+38.99%
est0.19EUR+165.86%
est0.07EUR+34.39%
0.05EUR+64.54%
0.03EUR+19.21%
0.03EUR+19.46%
0.02EUR-28.58%
0.03EUR+2.05%
0.03EUR+31.13%
0.02EUR-19.83%
0.03EUR-65.63%
0.09EUR+250.94%
0.02EUR-330.60%
-0.01EUR-85.90%
-0.08EUR-15.95%
-0.09EUR+187.50%
-0.03EUR-38.46%
-0.05EUR-142.62%
0.12EUR-3,150.00%
-0.00EUR-97.26%
-0.14EUR-194.64%
0.15EUR-59.00%
0.37EUR—
Access this data via the Eulerpool API
Get Free API Key

Lavipharm Stock analysis

What does Lavipharm do? Lavipharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lavipharm stock

EBIT per Share of Lavipharm is 0.05 EUR in 2025.

EBIT per Share of Lavipharm changed from 0.03 EUR to 0.05 EUR, representing a 64.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Lavipharm since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Lavipharm

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Lavipharm